Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TG1-H5254 | Human | Human TGF-beta RI Protein, Fc Tag (MALS verified) |  |
|
|
| TG1-H5259 | Human | Human TGFR-1 / ALK-5 / TGF-beta receptor type-1 Protein, Llama IgG2b Fc Tag (SPR verified) |  |
|
|
Human TGFB1, premium grade (Cat. No. TG1-H4212) immobilized on CM5 Chip can bind Human TGF-beta RI Protein, Fc Tag (Cat. No. TG1-H5254) with an affinity constant of 99.2 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Galunisertib | LY-2157299 | Phase 2 Clinical | Eli Lilly And Company | Nasopharyngeal Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Neoplasm Metastasis; Metastatic breast cancer; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Liver Neoplasms; Triple Negative Breast Neoplasms; Glioblastoma; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Solid tumours | Details |
| GF-101 | GFH-018; GF-101; GFH018 | Phase 2 Clinical | Genfleet Therapeutics (Shanghai) Co Ltd | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
| TU-2218 | TU-2218; NCE401; NCE-401 | Phase 2 Clinical | TiumBio Co Ltd | Solid tumours; Idiopathic Pulmonary Fibrosis | Details |
| ORG-129 | ORG-129; AGMB-129 | Phase 2 Clinical | Origo Biopharma Sociedad Litmitada | Crohn Disease | Details |
| TRK-250 | TRK-250; BNC-1021 | Phase 1 Clinical | Bonac Corp | Idiopathic Pulmonary Fibrosis | Details |
| Itacnosertib | TP-0184 | Phase 1 Clinical | Tolero Pharmaceuticals Inc, Sumitomo Dainippon | Solid tumours; Anemia | Details |
| Oxinseti | SH-3051 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Liver Neoplasms; Solid tumours | Details |
| AGMB-447 | AGMB-447; ORG-447 | Phase 1 Clinical | AgomAb Therapeutics NV | Idiopathic Pulmonary Fibrosis | Details |
This web search service is supported by Google Inc.
A-Z
